Goodrx Holdings Inc (GDRX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Goodrx Holdings Inc (GDRX) has a cash flow conversion efficiency ratio of 0.127x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($76.02 Million) by net assets ($600.71 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Goodrx Holdings Inc to measure how much of total assets are equity-financed.
Goodrx Holdings Inc - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Goodrx Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Goodrx Holdings Inc (GDRX) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Goodrx Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Goodrx Holdings Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guangzhou Echom Sci&Tech Co Ltd
SHE:002420
|
-0.033x |
|
Emira Property Fund
JSE:EMI
|
0.006x |
|
Putnam Premier Income Trust
NYSE:PPT
|
N/A |
|
TechTarget, Inc. Common Stock
NASDAQ:TTGT
|
-0.015x |
|
CoastalSouth Bancshares, Inc.
NYSE:COSO
|
-0.078x |
|
Shenzhen Kexin Communication Technologies Co Ltd
SHE:300565
|
-0.061x |
|
ENDOMINES FINLAND OYJ EO1
F:H13
|
N/A |
|
Muang Thai Insurance Public Company Limited
BK:MTI
|
0.031x |
Annual Cash Flow Conversion Efficiency for Goodrx Holdings Inc (2018–2024)
The table below shows the annual cash flow conversion efficiency of Goodrx Holdings Inc from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see GDRX market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $724.66 Million | $183.89 Million | 0.254x | +39.82% |
| 2023-12-31 | $761.96 Million | $138.29 Million | 0.181x | +0.75% |
| 2022-12-31 | $814.83 Million | $146.78 Million | 0.180x | -16.20% |
| 2021-12-31 | $831.68 Million | $178.78 Million | 0.215x | +16.43% |
| 2020-12-31 | $711.36 Million | $131.34 Million | 0.185x | +341.10% |
| 2019-12-31 | $-1.09 Billion | $83.29 Million | -0.077x | -96.71% |
| 2018-12-31 | $-1.16 Billion | $45.25 Million | -0.039x | -- |
About Goodrx Holdings Inc
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products … Read more